Research shows that when kidneys fail, the intestines continue absorbing too much phosphate from food even when blood phosphate levels are dangerously high, a problem that doesn’t occur in healthy people. According to Gram Research analysis, this happens because toxic substances that build up in kidney disease damage the protective barrier between intestinal cells, allowing more phosphate to leak through. Unlike healthy intestines that maintain steady phosphate absorption regardless of diet, damaged kidneys create a situation where the intestines lose their ability to regulate phosphate absorption, potentially requiring new treatments that target the intestinal barrier itself.
When your kidneys stop working properly, your body struggles to control phosphate levels, a mineral that needs to stay balanced for good health. According to Gram Research analysis, scientists discovered that damaged kidneys fail to turn off the intestines’ ability to absorb phosphate, even when there’s too much in the blood. The problem appears to be caused by toxic substances that build up in the body when kidneys fail, which damage the protective barrier in your intestines. This research suggests that targeting these toxic substances and intestinal barriers could help prevent serious mineral imbalances in people with kidney disease.
Key Statistics
A 2026 research study in mice found that healthy intestines absorbed the same amount of phosphate regardless of whether the diet contained less than 0.1% or 1.2% phosphate, showing that dietary phosphate changes do not trigger intestinal adaptation.
Mice with surgically damaged kidneys showed significantly higher intestinal phosphate absorption compared to healthy mice, and their intestines failed to reduce phosphate uptake despite dangerously elevated blood phosphate levels.
When human intestinal cells were exposed to p-cresol, a uremic toxin that accumulates in kidney disease, phosphate permeability increased, suggesting that toxic substances directly damage the intestinal barrier.
The study identified mislocalization of claudin-3 and claudin-7 proteins in the intestines of kidney-damaged mice, indicating structural damage to the tight junctions that normally control what passes through the intestinal wall.
The Quick Take
- What they studied: How the intestines absorb phosphate (a mineral in food) when kidneys are working normally versus when they’re damaged, and whether eating more or less phosphate changes how much gets absorbed.
- Who participated: Male laboratory mice were divided into groups: some ate low-phosphate diets, some ate high-phosphate diets, and some had surgery to damage their kidneys to mimic chronic kidney disease. Researchers also tested human intestinal cells in the laboratory.
- Key finding: Healthy mice kept absorbing the same amount of phosphate through their intestines no matter how much phosphate they ate, showing the intestines don’t adapt to dietary changes. Mice with damaged kidneys absorbed even more phosphate and couldn’t turn off this absorption process, even though their blood phosphate levels were dangerously high.
- What it means for you: If you have kidney disease, your intestines may absorb too much phosphate from food regardless of how much you eat, making it harder to control phosphate levels. This suggests future treatments might need to target the intestinal barrier itself rather than just restricting phosphate in your diet. Talk to your doctor about phosphate management if you have kidney disease.
The Research Details
Researchers used laboratory mice to study how phosphate moves from the intestines into the bloodstream. They fed some mice a low-phosphate diet (less than 0.1% phosphate) and others a high-phosphate diet (1.2% phosphate) for one week, then measured how much phosphate their bodies absorbed and how their kidneys handled it.
In a second experiment, they surgically removed most of the kidney tissue from mice (a procedure called 5/6 nephrectomy) to create a model of chronic kidney disease. These mice then ate a high-phosphate diet for two weeks while researchers measured phosphate absorption and studied changes in the intestinal barrier.
The team examined intestinal tissue under microscopes, measured protein levels, and tested how phosphate moved across the intestinal wall. They also grew human intestinal cells in dishes and exposed them to uremic toxins (poisonous substances that build up when kidneys fail) to see if these toxins affected phosphate absorption.
This research approach matters because it separates what happens in healthy bodies from what happens in diseased bodies. By testing both normal and kidney-damaged mice, researchers could identify which problems are specific to kidney disease rather than normal responses to diet changes. Testing human cells in the laboratory helps confirm that findings from mice might apply to people.
This study used controlled laboratory conditions with mice, which allows precise measurement but may not perfectly match how human bodies work. The researchers measured multiple markers of kidney function and phosphate metabolism, strengthening their findings. They examined both the movement of phosphate and the physical structures that control it, providing multiple lines of evidence. However, the study was conducted in animals and laboratory cells, so human studies would be needed to confirm these results apply to people with kidney disease.
What the Results Show
Healthy mice showed a surprising result: when researchers changed their diet from low-phosphate to high-phosphate, the amount of phosphate absorbed through the intestinal walls stayed almost exactly the same. This suggests that healthy intestines do not automatically adjust their phosphate absorption based on how much phosphate you eat. The intestines absorbed phosphate through two routes: active transport (which requires energy) and paracellular transport (which is passive movement through spaces between cells). The paracellular route handled most of the phosphate absorption when phosphate intake was high.
Mice with damaged kidneys showed a completely different pattern. Their intestines continued absorbing large amounts of phosphate even though their blood phosphate levels were dangerously high. Normally, when blood phosphate gets too high, the body should send signals to reduce intestinal absorption, but this didn’t happen in the kidney-damaged mice. The researchers found that proteins called claudins, which form the tight junctions (seals between intestinal cells), were misplaced and not functioning properly in the damaged kidney mice.
When researchers exposed human intestinal cells to p-cresol, a toxic substance that builds up in people with kidney failure, the cells became more permeable to phosphate. This suggests that uremic toxins directly damage the intestinal barrier, allowing more phosphate to leak through.
The study found that certain claudin proteins (claudin-3, claudin-4, and claudin-7) increased in the intestines when mice ate high-phosphate diets, suggesting the body tries to compensate for high phosphate intake by strengthening the intestinal barrier. However, this adaptation failed in mice with kidney disease. The researchers also observed that mice with damaged kidneys had the expected problems with mineral metabolism, including high blood phosphate and calcium imbalances, confirming that their kidney disease model accurately mimicked human chronic kidney disease.
Previous research suggested that the intestines might reduce phosphate absorption when kidneys fail, similar to how they adapt to other dietary changes. This study contradicts that assumption by showing that intestinal phosphate absorption actually increases in kidney disease rather than decreasing. The finding that uremic toxins damage the intestinal barrier is consistent with growing evidence that kidney disease causes widespread damage throughout the body, not just in the kidneys themselves. This research adds to our understanding that kidney disease creates a vicious cycle: damaged kidneys can’t remove phosphate, toxic substances build up, these toxins damage the intestinal barrier, and more phosphate gets absorbed, making the problem worse.
This research was conducted in mice, and mouse intestines may not behave exactly like human intestines. The study used laboratory mice with surgically damaged kidneys, which is not identical to how chronic kidney disease develops naturally in humans over time. The researchers did not test whether blocking or modifying claudin proteins would actually reduce phosphate absorption in living animals, so it remains unclear whether targeting these proteins would help patients. The study focused on one type of uremic toxin (p-cresol) but many other toxic substances build up in kidney disease, and their effects were not tested. Finally, the sample size of mice used was not specified in the abstract, making it difficult to assess the statistical power of the findings.
The Bottom Line
If you have chronic kidney disease, work closely with your nephrologist (kidney doctor) and dietitian on phosphate management. While restricting dietary phosphate remains important, this research suggests that diet alone may not be sufficient because your intestines may absorb phosphate regardless of intake levels. Ask your doctor about phosphate binders (medications that prevent phosphate absorption) and whether new treatments targeting intestinal barrier function might become available. Monitor your blood phosphate levels regularly as recommended by your healthcare team. This research is preliminary and based on animal studies, so treatment recommendations should come from your medical team.
People with chronic kidney disease, especially those in advanced stages, should pay attention to this research. Healthcare providers treating kidney disease patients should consider these findings when counseling patients about phosphate management. Researchers developing new kidney disease treatments should explore intestinal barrier function and uremic toxins as therapeutic targets. People with early-stage kidney disease should understand that phosphate control becomes increasingly important as kidney function declines. This research is less relevant for people with normal kidney function.
If new treatments targeting intestinal barriers are developed based on this research, it would likely take several years of human testing before they become available. In the meantime, people with kidney disease should expect to manage phosphate through diet, phosphate binders, and regular monitoring. Benefits from improved phosphate control typically appear over weeks to months as blood levels normalize and symptoms improve.
Frequently Asked Questions
Why do people with kidney disease have trouble controlling phosphate levels?
Damaged kidneys can’t remove excess phosphate from the blood, and toxic substances that build up in kidney disease damage the intestinal barrier, causing the intestines to absorb more phosphate than normal. This creates a double problem that diet alone cannot solve.
Does eating less phosphate help if you have kidney disease?
Reducing phosphate intake is still important, but this research suggests it may not be enough. Kidney disease patients’ intestines absorb phosphate regardless of dietary intake due to barrier damage, so medications like phosphate binders are often necessary alongside dietary restriction.
What are uremic toxins and how do they affect phosphate absorption?
Uremic toxins are poisonous substances that accumulate when kidneys fail to filter them out. Research shows that p-cresol, one uremic toxin, directly damages the intestinal barrier and increases phosphate permeability, allowing more phosphate to enter the bloodstream.
Could targeting the intestinal barrier help treat phosphate problems in kidney disease?
This research suggests that intestinal barrier function and uremic toxins could become therapeutic targets for managing phosphate in kidney disease. However, these are preliminary findings from animal studies, and human trials would be needed before new treatments become available.
How is this research different from previous understanding of kidney disease and phosphate?
Previous research suggested intestines might reduce phosphate absorption when kidneys fail. This study shows the opposite: intestinal phosphate absorption actually increases in kidney disease, and the intestinal barrier itself becomes damaged, not just less active.
Want to Apply This Research?
- Log daily phosphate intake using a food database, track blood phosphate levels from lab results at each doctor visit, and record phosphate binder medication adherence. Create a simple chart showing phosphate levels over time to identify patterns and discuss with your healthcare team.
- Set reminders to take phosphate binders with meals, use the app to identify high-phosphate foods in your diet, and log which foods you’re avoiding. Create a personalized list of phosphate-friendly foods you enjoy and track your adherence to your dietitian’s recommendations.
- Establish a baseline of your current blood phosphate level and set a target range with your doctor. Check phosphate levels at each lab appointment and log results in the app. Track trends over 3 to 6 months to see if your current management strategy is working. Share this data with your healthcare team to adjust treatment as needed.
This research is based on animal studies and laboratory cell experiments. While findings are promising, they have not yet been tested in humans. If you have chronic kidney disease, consult your nephrologist or kidney specialist before making any changes to your diet, medications, or phosphate management plan. Do not use this information to replace medical advice from your healthcare provider. Blood phosphate management is critical for people with kidney disease and should be supervised by qualified medical professionals.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.